| Home | E-Submission | Sitemap | Contact Us |  
Korean Journal of Clinical Oncology > Article
Korean J Clin Oncol. 2008;4(2): 37-41.         doi: https://doi.org/10.14216/kjco.08013
Adjuvant Chemotherapy for Gastric Cancer
Sung Soo Park, Young Jae Mok
Department of Surgery, Korea University College of Medicine, Seoul, Korea
위암의 보조 항암요법
박성수, 목영재
고려대학교 의과대학 외과학교실
Corresponding Author: Sung Soo Park ,Tel: +82-2-920-6772, Fax: +82-2-928-1631, Email: kugspss@korea.ac.kr
Received: October 2, 2008;  Accepted: November 30, 2008.
Share :  
The fact that systemic therapy in addition to definitive regional treatment improves outcome for breast and colon cancer is well established, but whether this is also the case for patients with gastric cancer has not been determined. Despite three recent studies have clearly demonstrated that even modestly effective systemic therapy in combination with surgery produces superior outcomes to surgery alone, no globally accepted standard regimen has yet been established. However, now the benefits of adjuvant chemotherapy seem to be convincing since the advent of the three pivotal studies. Safer, more convenient and more effective chemotherapy combinations are being developed. We need to know about these challenges and how to select the optimal therapy for an individual patient. In this update, I will review the recent studies and provide issues focusing on optimal adjuvant chemotherapy for resectable gastric cancer.
Keywords: Adjuvant chemotherapy | Gastric cancer
Editorial Office
101-3304 Brownstone Seoul, 464 Cheongpa-ro, Jung-gu, Seoul 04510, Korea
TEL : +82-2-393-2114   FAX : +82-2-393-1649   E-mail : ksco2004@daum.net

Copyright© Korean Society of Surgical Oncology.                Developed in M2PI
About |  Browse Articles |  Current Issue |  For Authors and Reviewers